Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study
BackgroundNo phase 3 studies have yet been conducted for patients with non–clear cell (CC) renal cell carcinoma (RCC) exclusively due to the rare occurrence of the disease and the heterogenicity in tumor morphology. Consequently, there is no evidence of the optimal treatment,...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-09-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2022/9/e36632 |